News & Press | AmbioPharm - Part 3

AmbioPharm and ONL Therapeutics logos

AmbioPharm Supports ONL Therapeutics with Peptide Manufacturing to Prepare for IND Application for Phase 2 Study

July 12, 2022

Adalvo announces successful launch of Icatibant in close collaboration with strategic partner Ambio

January 27, 2022

Adalvo announces successful DCP closure for Icatibant in close collaboration with strategic partner AmbioPharm

September 28, 2021

CEM Corporation and AmbioPharm Form U.S. Partnership for GMP Peptide Production

CEM Corporation and AmbioPharm Form U.S. Partnership for GMP Peptide Production

September 14, 2021

AmbioPharm Inc. Working with University of California Davis to Develop Non-Opioid Peptide-Based Pain Therapeutics

July 20, 2021

AmbioPharm Inc. Announces New Shanghai Campus Opening and European Executive Team Members

January 7, 2021

Upsher-Smith and AmbioPharm Announce Partnership Agreement to Develop and Market Corticotropin Injection

August 10, 2020

Adalvo and AmbioPharm partner on development & licensing for key peptide products

July 29, 2020

SETTING A NEW STANDARD

For Peptide API Manufacturing and Services

Have a Peptide project?

SUBMIT YOUR REQUIREMENTS